Last reviewed · How we verify
Silver Sulfadiazine Cream 1%
Silver Sulfadiazine Cream 1% is a Topical antibacterial agent Small molecule drug developed by Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara. It is currently in Phase 3 development for Prevention of wound and burn infections. Also known as: Silver Sulfadiazine.
Silver sulfadiazine cream acts as a topical antibacterial agent, inhibiting bacterial growth and preventing infection in burns and wounds.
Silver sulfadiazine cream acts as a topical antibacterial agent, inhibiting bacterial growth and preventing infection in burns and wounds. Used for Prevention of wound and burn infections.
At a glance
| Generic name | Silver Sulfadiazine Cream 1% |
|---|---|
| Also known as | Silver Sulfadiazine |
| Sponsor | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara |
| Drug class | Topical antibacterial agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Silver sulfadiazine works by releasing silver ions, which have broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria. This helps to prevent the growth of bacteria in wounds and burns, reducing the risk of infection.
Approved indications
- Prevention of wound and burn infections
Common side effects
- Skin irritation
Key clinical trials
- Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns (PHASE2)
- SWC for Treatment of Superficial Partial-Thickness Burns (NA)
- Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection (NA)
- Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns (PHASE4)
- Pediatric Burn Treatment Using Tilapia Skin as a Xenograft for Superficial-Partial Thickness Wounds (PHASE2)
- Use of Nile Tilapia Fish Skin as a Xenograft for Burn Treatment: Phase III Study (PHASE3)
- Clinical Evaluation and Generalized Application of "Qing-Hua-Bu" Three Dynamic Sequential Therapy of Diabetic Ulcer (PHASE2)
- Mepilex Ag Versus Silver Sulfadiazine in Children and Adults With Burn Injuries. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Silver Sulfadiazine Cream 1% CI brief — competitive landscape report
- Silver Sulfadiazine Cream 1% updates RSS · CI watch RSS
- Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara portfolio CI
Frequently asked questions about Silver Sulfadiazine Cream 1%
What is Silver Sulfadiazine Cream 1%?
How does Silver Sulfadiazine Cream 1% work?
What is Silver Sulfadiazine Cream 1% used for?
Who makes Silver Sulfadiazine Cream 1%?
Is Silver Sulfadiazine Cream 1% also known as anything else?
What drug class is Silver Sulfadiazine Cream 1% in?
What development phase is Silver Sulfadiazine Cream 1% in?
What are the side effects of Silver Sulfadiazine Cream 1%?
Related
- Drug class: All Topical antibacterial agent drugs
- Manufacturer: Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Prevention of wound and burn infections
- Also known as: Silver Sulfadiazine
- Compare: Silver Sulfadiazine Cream 1% vs similar drugs
- Pricing: Silver Sulfadiazine Cream 1% cost, discount & access